OTCMKTS:REPR - Repro-Med Systems Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.23 -0.02 (-1.60 %) (As of 08/17/2018 04:00 PM ET)Previous Close$1.23Today's Range$1.22 - $1.2652-Week Range$0.3610 - $1.50Volume15,200 shsAverage Volume12,532 shsMarket Capitalization$53.37 millionP/E RatioN/ADividend YieldN/ABeta-0.76 Company ProfileChartEarnings HistoryFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Repro Med Systems, Inc. designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system. The company sells its products directly to physician offices, hospitals, and other institutional customers, as well as through regional distributors specializing in the hospital respiratory care market. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York. Receive REPR News and Ratings via Email Sign-up to receive the latest news and ratings for REPR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolOTCMKTS:REPR CUSIPN/A Webwww.repro-med.com Phone845-469-2042 Debt Debt-to-Equity RatioN/A Current Ratio5.77 Quick Ratio4.66 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$12.24 million Price / Sales3.88 Cash FlowN/A Price / CashN/A Book Value$0.18 per share Price / Book6.83 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees69 Outstanding Shares38,590,000Market Cap$53.37 million Repro-Med Systems (OTCMKTS:REPR) Frequently Asked Questions What is Repro-Med Systems' stock symbol? Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR." How were Repro-Med Systems' earnings last quarter? Repro-Med Systems, Inc. (OTCMKTS:REPR) posted its quarterly earnings results on Monday, August, 6th. The company reported $0.01 EPS for the quarter. The firm had revenue of $4.50 million for the quarter. View Repro-Med Systems' Earnings History. Who are some of Repro-Med Systems' key competitors? Some companies that are related to Repro-Med Systems include RenovaCare (RCAR), SeaSpine (SPNE), Liquidia Technologies (LQDA), Apollo Endosurgery (APEN), Alphatec (ATEC), Sensus Healthcare (SRTS), Motus GI (MOTS), Invuity (IVTY), CAS Medical Systems (CASM), Invo Bioscience (IVOB), Neovasc (NVCN), Arch Therapeutics (ARTH), Spectral Medical (EDTXF), SANUWAVE Health, Inc. Common Stock (SNWV) and iCAD (ICAD). Who are Repro-Med Systems' key executives? Repro-Med Systems' management team includes the folowing people: Mr. Andrew I. Sealfon, Co-Founder, Chairman, CEO, Pres and Head of R&D (Age 72)Ms. Karen Fisher, CFO, Treasurer & Corp. Sec. (Age 52)Dr. Fred L. Ma, Chief Medical Officer (Age 58)Mr. Steven Kamphausen, Global VP of Sales & Marketing Has Repro-Med Systems been receiving favorable news coverage? Media coverage about REPR stock has been trending very positive this week, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Repro-Med Systems earned a daily sentiment score of 0.52 on Accern's scale. They also gave news stories about the company an impact score of 48.56 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Repro-Med Systems. How do I buy shares of Repro-Med Systems? Shares of REPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Repro-Med Systems' stock price today? One share of REPR stock can currently be purchased for approximately $1.23. How big of a company is Repro-Med Systems? Repro-Med Systems has a market capitalization of $53.37 million and generates $12.24 million in revenue each year. Repro-Med Systems employs 69 workers across the globe. How can I contact Repro-Med Systems? Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected] MarketBeat Community Rating for Repro-Med Systems (OTCMKTS REPR)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 43 (Vote Outperform)Underperform Votes: 53 (Vote Underperform)Total Votes: 96MarketBeat's community ratings are surveys of what our community members think about Repro-Med Systems and other stocks. Vote "Outperform" if you believe REPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REPR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/18/2018 by MarketBeat.com StaffFeatured Article: What kind of dividend yield to CEF's pay?